Wide Ranks

BLRX

BioLineRx Ltd.

0.2870

Top Statistics
Market Cap 28 M Forward PE -2.61 Revenue Growth 0.00 %
Current Ratio 1.61 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -176.67 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -9.58 Enterprise / Revenue 18.59 Price To Sales Trailing12 Months 1.64
Profitability
Profit Margins -176.67 % Operating Margins -107.05 %
Balance Sheet
Total Cash 40 M Total Cash Per Share 0.0330 Total Debt 31 M
Total Debt To Equity 223.55 Current Ratio 1.61 Book Value Per Share 0.0120
All Measures
Short Ratio 239.00 % Message Board Id finmb_5015080 Fax 972 8 642 9101
Shares Short Prior Month 137659 Return On Equity -1.72 City Hevel Modi'in
Uuid e62a36f1-05bb-3c53-9aee-d33adfbdf394 Previous Close 0.2762 First Trade Date Epoch Utc 1 B
Book Value 0.0120 Beta 0.8730 Total Debt 31 M
Volume 1 M Price To Book 23.92 Last Split Date 1 B
Fifty Two Week Low 0.2500 Total Cash Per Share 0.0330 Total Revenue 17 M
Shares Short Previous Month Date 1 B Target Median Price 6.50 Max Age 86400
Recommendation Mean 1.50 Sand P52 Week Change 0.3133 Operating Margins -107.05 %
Target Mean Price 5.83 Net Income To Common -30119000 Short Percent Of Float 0.0133
Implied Shares Outstanding 75 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 2 M Average Volume10days 2 M Total Cash 40 M
Next Fiscal Year End 1 B Revenue Per Share 0.2400 Held Percent Insiders 0.0854
Ebitda Margins -194.04 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.2762 Target Low Price 2.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.4698 Open 0.2800
Free Cashflow -15807125 Dividend Yield 0.00 % Return On Assets -0.3523
Time Zone Short Name EST Trailing Eps -0.3000 Day Low 0.2719
Address1 Modi’in Technology Park Shares Outstanding 84 M Price Hint 4
Target High Price 9.00 Website https://www.biolinerx.com 52 Week Change -0.8000
Average Volume 722501 Forward Eps -0.2200 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 143.80 % Last Split Factor 1:15
Regular Market Day High 0.3000 Is_sp_500 False Profit Margins -176.67 %
Debt To Equity 223.55 Fifty Two Week High 1.89 Day High 0.3000
Shares Short 1 M Regular Market Open 0.2800 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 18.59 Revenue Growth 0.00 %
Shares Percent Shares Out 0.0133 Operating Cashflow -30348000 Currency USD
Time Zone Full Name America/New_York Market Cap 28 M Is_nasdaq_100 False
Zip 7177871 Quote Type EQUITY Industry Biotechnology
Long Name BioLineRx Ltd. Regular Market Day Low 0.2719 Held Percent Institutions 0.0309
Current Price 0.2870 Address2 2 HaMa’ayan Street Enterprise To Ebitda -9.58
Financial Currency USD Current Ratio 1.61 Gross Margins 64.55 %
Industry Disp Biotechnology Number Of Analyst Opinions 3 Country Israel
Float Shares 1 B Two Hundred Day Average 0.7113 Enterprise Value 316 M
Price To Sales Trailing12 Months 1.64 Forward PE -2.61 Regular Market Volume 1 M
Ebitda -33080000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
BioLineRx Ltd.

, a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma.

It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions.

BioLineRx Ltd.

was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.